Familial hypercholesterolemia: Current treatment options and patient selection for low-density lipoprotein apheresis

Journal of Clinical Lipidology

Volumn 4, Issue 5, 2010, Pages 346-349

  Hemphill, Linda C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Apheresis; Familial hypercholesterolemia; LDL; Patient selection; Statins

Indexed keywords

APOLIPOPROTEIN B; ATORVASTATIN; EZETIMIBE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; NICOTINIC ACID; ROSUVASTATIN; SIMVASTATIN;

APHERESIS; CONFERENCE PAPER; FAMILIAL HYPERCHOLESTEROLEMIA; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MORBIDITY; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

ANTICHOLESTEREMIC AGENTS; AZETIDINES; BLOOD COMPONENT REMOVAL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEINS, LDL; PATIENT SELECTION; RECEPTORS, LDL;

EID: 77957861112     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2010.08.013     Document Type: Conference Paper

References (18)

1. H. Buchwald, R.L. Varco, J.P. Matts the POSCH Group Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: report of the Program on the Surgical Control of the Hyperlipidemias (POSCH) N Engl J Med 323 1990 946 955
2. P.T. Kuo, J.B. Kostis, A.E. Moreyra, and J.A. Hayes Familial type II hyperlipoproteinemia with coronary heart disease: effect of diet-colestipol- nicotinic acid treatment Chest 79 1981 286 291
3. E.A. Stein, K. Strutt, H. Southworth, P.J. Diggle, and E. Miller Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia Am J Cardiol 92 2003 1287 1293
4. J.J.P. Kastelein, F. Akdim, and E.S.G. Stroes Simvastatin with or without ezetimibe in familial hypercholesterolemia N Engl J Med 358 2008 1431 1443
5. Y. Noji, T. Higashikata, and A. Inazu Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia Atherosclerosis 163 2002 157 164
6. S.B. Clauss, K.W. Holmes, and P. Hopkins Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia Pediatrics 116 2005 682 688
7. S. de Jongh, L. Ose, and T. Szamosi Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized double-blind, placebo-controlled trial with simvastatin Circulation 106 2002 2231
8. B.W. McCrindle, L. Ose, and A.D. Marais Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial J Pediatr 143 2003 74 80
9. H.J. Avis, B.A. Hutten, and C. Gagne Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia J Am Coll Cardiol 55 2010 1121 1126
10. Scientific Steering committee on behalf of the Simon-Broome Register Group Mortality in treated heterozygous familial hypercholesterolemia: implication for clinical management Atherosclerosis 142 1999 105 112
11. J. Versmissen, D.M. Oosterveer, and M. Yazdanpanah Efficacy of statins in familial hypercholesterolemia: a long term cohort study BMJ 337 2008 a2423
12. M.M. Cobb, H.S. Teitelbaum, and J.L. Breslow Lovastatin efficacy in reducing low-density lipoprotein cholesterol levels on high- vs low-fat diets JAMA 265 1991 997 1001
13. J.R. Raal, G.J. Pilcher, and D.R. Illingworth Expanded-dose simvastatin is effective in homozygous familial hypercholesterolemia Atherosclerosis 135 1997 249 256
14. A.D. Marais, F.J. Raal, and E.A. Stein A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolemia Atherosclerosis 197 2008 400 406
15. C. Gagne, D. Gaudet, and E. Bruckert Efficacy and safety of ezetimibe co administered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia Circulation 105 2002 2469 2475
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
17. S.M. Grundy, J.I. Cleeman, N. Bairey Merz for the Coordinating Committee of the National Cholesterol Education Program Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines Circulation 110 2004 227 239
18. J.C. LaRosa, S.M. Grundy, and D.D. Waters Intensive lipid lowering with atorvastatin in patients with stable coronary disease N Engl J Med 352 2005 1425 1435